Quotient Sciences and CPI to Form JV to Accelerate RNA Drug Development
Quotient Sciences and UK innovation centre CPI have signed an MoU to form a joint venture that will accelerate the development of RNA-based therapies through an integrated, end-to-end platform.
Thierry Van Nieuwenhove | 03/09/2025 | By Mrinmoy Dey | 128
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy